GlassScriptPhysician profile
Charles A Anene
NPI 1124108303
$2,477.28
in general payments reported to CMS, 2019-2025
32 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $144 · 2021: $259 · 2022: $389 · 2023: $504 · 2024: $487 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $344.03 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $245.77 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Ethicon US, LLC | $217.08 | 2019-2022 | |
| Medtronic, INC. | $211.41 | 2021-2025 | Protege Rx, In.Pact Admiral, Ellipsys Vascular Access System |
| Atricure, INC. | $193.63 | 2019-2024 | |
| Chiesi USA, INC. | $174.39 | 2019-2022 | |
| Getinge USA Sales, LLC | $149.17 | 2021-2024 | Vasoview Hemopro 2, Cardioroot |
| Novartis Pharmaceuticals Corporation | $109.33 | 2019-2022 | |
| Lemaitre Vascular, INC. | $106.58 | 2020-2025 | Hydro Lemaitre Valvulotome, Restoreflow |
| Shockwave Medical, INC | $101.26 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $99.38 | 2020-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Venovo |
| Abbott Laboratories | $52.03 | 2023 | Epic |
| Cook Medical LLC | $47.10 | 2022-2025 | Zenith Alpha, Zenith Spiral-Z |
| Cardiovascular Systems INC. | $39.67 | 2021-2022 | |
| Kls-Martin L.P. | $36.90 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $32.25 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $28.71 | 2024 | Keytruda |
| Janssen Pharmaceuticals, INC | $28.06 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $27.82 | 2019 | |
| Boston Scientific Corporation | $25.55 | 2022 | |
| Medtronic Vascular, INC. | $21.90 | 2019 | |
| Abiomed | $21.80 | 2020 | |
| Biomerieux INC | $21.10 | 2023 | Nephrocheck Liquid Control Kit |
| Pfizer INC. | $20.64 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.33 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.17 | 2022 | |
| Bolton Medical INC | $16.82 | 2023 | Treo Abdominal Stent-Graft System |
| Next Science LLC | $15.44 | 2021 | |
| Elutia, INC. | $13.35 | 2021 | |
| Veran Medical Technologies, INC. | $12.41 | 2019 | |
| Baxter Healthcare | $12.14 | 2022 | |
| Amgen INC. | $12.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Anene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.